Brianna Bresett, | |
33 Forest Park Ave, Adams, MA 01220-1818 | |
(413) 822-3434 | |
Not Available |
Full Name | Brianna Bresett |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 33 Forest Park Ave, Adams, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790141174 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brianna Bresett, 33 Forest Park Ave, Adams, MA 01220-1818 Ph: () - | Brianna Bresett, 33 Forest Park Ave, Adams, MA 01220-1818 Ph: (413) 822-3434 |
News Archive
Childhood high blood pressure (HBP) is a serious public health challenge worldwide due to associated increases in risk of end organ damages and correlation with HBP in adulthood. The prevalence of elevated blood pressure (BP) has been reported to increase significantly among United States children and adolescents from 1988-1994 to 1999-2008, but little is known about recent trends in BP values and elevated BP.
Researchers at the University of North Carolina at Chapel Hill have conducted a study exploring how the spatial patterning of certain genomic RNA regions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes compaction, packaging, and cyclization of the viral genome.
Electronic health record systems likely will soon become a fixture in medical settings. Advocates claim they will reduce health care costs and improve medical outcomes, which could be critical since the new health care reform law increases access for millions of Americans. Although benefits of bringing information technology to health records can be substantial, EHR systems also give rise to increased liability risks for health care providers due to possible software or hardware problems or user errors.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 8 days ago